Stock RCKT ROCKET PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Rocket Pharmaceuticals, Inc.

Equities

RCKT

US77313F1066

Market Closed - Nasdaq
Other stock markets
 03:59:48 2024-06-04 pm EDT 		5-day change 1st Jan Change
22.21 USD +1.28% Intraday chart for Rocket Pharmaceuticals, Inc. +6.06% -25.89%
May. 29 Rocket Pharmaceuticals' Gene Therapy for Inherited Heart Disease Receives Orphan Drug Designation in Europe MT
May. 16 Transcript : Rocket Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ROCKET PHARMACEUTICALS, INC. Stock Rocket Pharmaceuticals, Inc.
 2.02B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.01B -
ARGENX SE Stock argenx SE
 22.59B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. RCKT Stock
  4. Charts Rocket Pharmaceuticals, Inc.
  5. Sector Chart